Ekkehart Paditz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ekkehart Paditz has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Angelika Anita Schlarb
Faculty of Psychology and Sports Science, Bielefeld University, 33615 Bielefeld, Germany
3 shared publications Mirja Quante
Abt. Neonatologie Klinik für Kinder-und Jugendmedizin Universitätsklinikum Tübingen Tübingen Deutschland
3 shared publications- Osman S. Ipsiroglu
Interdisciplinary Sleep Program, Sleep/Wake-Behaviour Clinic, Departments of Pediatrics & Psychiatry, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
3 shared publications - Alfred Wiater
Köln, Deutschland
2 shared publications Barbara Schneider
Sozialpädiatrisches Zentrum Landshut am Kinderkrankenhaus St. Marien gGmbH, Landshut, Deutschland
2 shared publications- Barbara Schneider
Zentrum für Neuropädiatrie und Schlafmedizin, Kinderklinik St. Marien, Landshut, Deutschland
2 shared publications
Latest Publications
- Open Access
Current Advances in Pediatric Sleep Medicine, Vol. 1
Although, at present, there is no holistic and transdisciplinary understanding of ‘sleep in infancy, childhood and adolescence’
Open AccessCurrent Advances in Pediatric Sleep Medicine, Vol. 1
Although, at present, there is no holistic and transdisciplinary understanding of ‘sleep in infancy, childhood and adolescence’
- Open Access
- 24 November 2025
- Published by Taylor & Francis in Journal of the History of the Neurosciences
- Vol. 35 (2) , 109-155
The pineal gland as the seat of the soul (René Descartes): History of reception, enlightenment, and consequences of a famous error
René Descartes (1596-1650) was a brilliant thinker whose ideas are still reflected upon today. The Cartesian view that the pineal gland is the seat of the soul was criticized early on by Thomas Willis, Baruch Spinoza, Gottfried Wilhelm Leibniz, and Immanuel Kant, among others. Nevertheless, this historical error is still being propagated today: Helena Blavatsky supplemented this in 1888 with so-called ancient Indian knowledge about chakras, and Rudolf Steiner saw the human link to cosmic energies in the pineal calcite deposits in 1922/1923. These ideas can also be found in current medical studies. In this study, these sources are critically discussed transculturally in the context of current anatomical, physiological, and evolutionary biological knowledge.
- 24 November 2025
- Published by Taylor & Francis in Journal of the History of the Neurosciences
- Vol. 35 (2) , 109-155
Open AccessThe pineal gland as the seat of the soul (René Descartes): History of reception, enlightenment, and consequences of a famous error
René Descartes (1596-1650) was a brilliant thinker whose ideas are still reflected upon today. The Cartesian view that the pineal gland is the seat of the soul was criticized early on by Thomas Willis, Baruch Spinoza, Gottfried Wilhelm Leibniz, and Immanuel Kant, among others. Nevertheless, this historical error is still being propagated today: Helena Blavatsky supplemented this in 1888 with so-called ancient Indian knowledge about chakras, and Rudolf Steiner saw the human link to cosmic energies in the pineal calcite deposits in 1922/1923. These ideas can also be found in current medical studies. In this study, these sources are critically discussed transculturally in the context of current anatomical, physiological, and evolutionary biological knowledge.
- Open Access
The Pharmacokinetics, Dosage, Preparation Forms, and Efficacy of Orally Administered Melatonin for Non-Organic Sleep Disorders in Autism Spectrum Disorder During Childhood and Adolescence: A Systematic Review
Background: To date, it remains unclear which oral doses and preparation forms of melatonin should be recommended for children and adolescents with non-organic sleep disorders and autism spectrum disorder (ASD). We reviewed the current state of knowledge on this topic based on randomised placebo-controlled trials (RCTs) and diagnosis-related blood melatonin concentrations available in this age group. Method: Two investigators independently searched PubMed, PsycINFO, MEDLINE, and Cochrane CENTRAL on 1 March 2025 for the keywords “melatonin”, “autism”, and “randomised” in titles and abstracts in all languages, including an evaluation of the references of the reviews, systematic reviews, and meta-analyses published up to that date, some of which were based on searches in numerous databases. Based on this, additional in-depth searches were carried out in PubMed for pharmacokinetic, physiological, and pathophysiological data on melatonin in children and adolescents, with a special focus on ASD. Results: To date, five RCTs on non-organic sleep disorders in children and adolescents with the sole diagnosis of ASD or with subgroup analyses in the presence of several initial diagnoses such as ADHD, epilepsy, Smith–Magenis, or Fragile X syndrome are available. In these studies, rapid-release, non-delayed preparations were administered orally. In one of these studies, the clinical efficacy of a combination preparation with a sustained-release and a non-released active substance component was tested. Pharmacokinetic data with multiple determinations of melatonin concentrations in the blood are only available for children with ASD in the form of a case series (N = 9). Discussion: RCTs comparing the efficacy of delayed melatonin preparations with non-delayed rapid-release oral preparations are not yet available. Physiological data and clinical effects documented in five RCTs indicate that non-delayed melatonin preparations with an initial rapid onset of action are effective for non-organic sleep disorders in children and adolescents with ASD. Conclusions: From a clinical, pharmacokinetic, and physiological point of view, the RCTs available to date and the data on melatonin concentrations in the blood of children with ASD, measured several times over 24 h, suggest that a low oral melatonin dose and a non-delayed preparation with rapid onset should be started in children and adolescents with non-organic sleep disorders in ASD, if sleep hygiene advice and psychotherapeutic interventions have not demonstrated sufficient effects.
Open AccessThe Pharmacokinetics, Dosage, Preparation Forms, and Efficacy of Orally Administered Melatonin for Non-Organic Sleep Disorders in Autism Spectrum Disorder During Childhood and Adolescence: A Systematic Review
Background: To date, it remains unclear which oral doses and preparation forms of melatonin should be recommended for children and adolescents with non-organic sleep disorders and autism spectrum disorder (ASD). We reviewed the current state of knowledge on this topic based on randomised placebo-controlled trials (RCTs) and diagnosis-related blood melatonin concentrations available in this age group. Method: Two investigators independently searched PubMed, PsycINFO, MEDLINE, and Cochrane CENTRAL on 1 March 2025 for the keywords “melatonin”, “autism”, and “randomised” in titles and abstracts in all languages, including an evaluation of the references of the reviews, systematic reviews, and meta-analyses published up to that date, some of which were based on searches in numerous databases. Based on this, additional in-depth searches were carried out in PubMed for pharmacokinetic, physiological, and pathophysiological data on melatonin in children and adolescents, with a special focus on ASD. Results: To date, five RCTs on non-organic sleep disorders in children and adolescents with the sole diagnosis of ASD or with subgroup analyses in the presence of several initial diagnoses such as ADHD, epilepsy, Smith–Magenis, or Fragile X syndrome are available. In these studies, rapid-release, non-delayed preparations were administered orally. In one of these studies, the clinical efficacy of a combination preparation with a sustained-release and a non-released active substance component was tested. Pharmacokinetic data with multiple determinations of melatonin concentrations in the blood are only available for children with ASD in the form of a case series (N = 9). Discussion: RCTs comparing the efficacy of delayed melatonin preparations with non-delayed rapid-release oral preparations are not yet available. Physiological data and clinical effects documented in five RCTs indicate that non-delayed melatonin preparations with an initial rapid onset of action are effective for non-organic sleep disorders in children and adolescents with ASD. Conclusions: From a clinical, pharmacokinetic, and physiological point of view, the RCTs available to date and the data on melatonin concentrations in the blood of children with ASD, measured several times over 24 h, suggest that a low oral melatonin dose and a non-delayed preparation with rapid onset should be started in children and adolescents with non-organic sleep disorders in ASD, if sleep hygiene advice and psychotherapeutic interventions have not demonstrated sufficient effects.
- Open Access
- 7 May 2025
- Published by Springer Nature in Schmerzmedizin
- Vol. 41 (2) , 48-54
Melatonin bei Schlafstörungen im Kindes- und Jugendalter
- 7 May 2025
- Published by Springer Nature in Schmerzmedizin
- Vol. 41 (2) , 48-54
Open AccessMelatonin bei Schlafstörungen im Kindes- und Jugendalter
- Open Access
Postnatal Development of the Circadian Rhythmicity of Human Pineal Melatonin Synthesis and Secretion (Systematic Review)
Introduction: According to current knowledge, at birth, the pineal gland and melatonin receptors are already present and the suprachiasmatic nucleus is largely functional, and noradrenaline, the key pineal transmitter, can be detected in the early foetal period. It is still unclear why the pineal gland is not able to start its own pulsatile synthesis and secretion of melatonin in the first months of life, and as a result, infants during this time are dependent on an external supply of melatonin. Method: The causes and consequences of this physiological melatonin deficiency in human infancy are examined in a systematic review of the literature, in which 40 of 115 initially selected publications were evaluated in detail. The references of these studies were checked for relevant studies on this topic. References from previous reviews by the author were taken into account. Results: The development and differentiation of the pineal gland, the pinealocytes, as the site of melatonin synthesis, and the development and synaptic coupling of the associated predominantly noradrenergic neural pathways and vessels and the associated Lhx4 homebox only occurs during the first year of life. Discussion: The resulting physiological melatonin deficiency is associated with sleep disorders, infant colic, and increased crying in babies. Intervention studies indicate that this deficiency should be compensated for through breastfeeding, the administration of nonpooled donor milk, or through industrially produced chrononutrition made from nonpooled cow’s milk with melatonin-poor day milk and melatonin-rich night milk.
Open AccessPostnatal Development of the Circadian Rhythmicity of Human Pineal Melatonin Synthesis and Secretion (Systematic Review)
Introduction: According to current knowledge, at birth, the pineal gland and melatonin receptors are already present and the suprachiasmatic nucleus is largely functional, and noradrenaline, the key pineal transmitter, can be detected in the early foetal period. It is still unclear why the pineal gland is not able to start its own pulsatile synthesis and secretion of melatonin in the first months of life, and as a result, infants during this time are dependent on an external supply of melatonin. Method: The causes and consequences of this physiological melatonin deficiency in human infancy are examined in a systematic review of the literature, in which 40 of 115 initially selected publications were evaluated in detail. The references of these studies were checked for relevant studies on this topic. References from previous reviews by the author were taken into account. Results: The development and differentiation of the pineal gland, the pinealocytes, as the site of melatonin synthesis, and the development and synaptic coupling of the associated predominantly noradrenergic neural pathways and vessels and the associated Lhx4 homebox only occurs during the first year of life. Discussion: The resulting physiological melatonin deficiency is associated with sleep disorders, infant colic, and increased crying in babies. Intervention studies indicate that this deficiency should be compensated for through breastfeeding, the administration of nonpooled donor milk, or through industrially produced chrononutrition made from nonpooled cow’s milk with melatonin-poor day milk and melatonin-rich night milk.
- Open Access
- 30 July 2024
- Published by MDPI AG in Preprints.org
Postnatal Development of Pineal Synthesis and Secretion of Melatonin
It is still unclear why the pineal gland is not able to start its own pulsatile synthesis and secretion of melatonin in the first months of a human's life, so that infants during this time are dependent on the external supply of melatonin via breast milk, unpooled donor milk from breast milk collection centres or industrially produced chrononutrition with melatonin-poor day milk and melatonin-rich night milk. According to current knowledge, the pineal gland and melatonin receptors are already present at birth, the suprachiasmatic nucleus is largely functional and noradrenaline, the key pineal transmitter, can be detected in the early foetal period. However, the development and differentiation of the pineal gland, the pinealocytes as the site of melatonin synthesis and the associated Lhx4 homebox only occurs during the first year of a person's life. The resulting "physiological" melatonin deficiency is associated with sleep disorders, infant colic and increased crying in babies. Intervention studies indicate that this deficiency should be compensated for – through breastfeeding, the administration of unpooled donor milk or through industrially produced chrononutrition made from unpooled cow's milk with melatonin-poor day milk and melatonin-rich night milk [1-3], see also Video [4].
- 30 July 2024
- Published by MDPI AG in Preprints.org
Open AccessPostnatal Development of Pineal Synthesis and Secretion of Melatonin
It is still unclear why the pineal gland is not able to start its own pulsatile synthesis and secretion of melatonin in the first months of a human's life, so that infants during this time are dependent on the external supply of melatonin via breast milk, unpooled donor milk from breast milk collection centres or industrially produced chrononutrition with melatonin-poor day milk and melatonin-rich night milk. According to current knowledge, the pineal gland and melatonin receptors are already present at birth, the suprachiasmatic nucleus is largely functional and noradrenaline, the key pineal transmitter, can be detected in the early foetal period. However, the development and differentiation of the pineal gland, the pinealocytes as the site of melatonin synthesis and the associated Lhx4 homebox only occurs during the first year of a person's life. The resulting "physiological" melatonin deficiency is associated with sleep disorders, infant colic and increased crying in babies. Intervention studies indicate that this deficiency should be compensated for – through breastfeeding, the administration of unpooled donor milk or through industrially produced chrononutrition made from unpooled cow's milk with melatonin-poor day milk and melatonin-rich night milk [1-3], see also Video [4].
- Open Access
- 26 April 2024
- Published by Springer Nature in Somnologie
- Vol. 28 (2) , 131-137
33 Praxis-Tipps für müde Eltern, um über den Tag zu kommen
Zusammenfassung: Hintergrund: Viele Eltern berichten, nach der Geburt ihres Kindes übermüdet zu sein und Schwierigkeiten zu haben, den Alltag zu bewältigen. Dies betrifft vor allem erstgebärende Mütter. Schlafmangel und Schlafschwierigkeiten gelten als Risikofaktor für viele Beeinträchtigungen wie Depression, Aggressivität, Abnahme der Beziehungsqualität und Kindeswohlgefährdung. Ziel dieser Arbeit war es daher, eine Reihe an Verhaltensempfehlungen für Eltern zu geben, um einer möglichen Gefährdung der eigenen Person oder des Kindes entgegenzuwirken. Methode: In einem interdisziplinären Team wurden basierend auf der gegenwärtigen Literatur sowie der klinischen Expertise die Empfehlungen formuliert, reflektiert und diskutiert. Ergebnisse: Es wurden insgesamt 33 Verhaltensempfehlungen für müde Eltern formuliert, die sich auf die Person selbst, die Partnerschaft und Familie, den Abend und die Nacht sowie die Arbeit beziehen. Die Empfehlungen sind vor allem für Eltern jüngerer Kinder geeignet. Diskussion: Mithilfe der hier formulierten Empfehlungen sollen alltagsnahe Hilfen geschaffen werden, um Eltern niederschwellig Unterstützung zukommen zu lassen. Solche Tipps können als Selbsthilfemaßnahmen, als Basis für eine Schlafberatung sowie für eine weiterführende ausführliche Behandlung dienen.
- 26 April 2024
- Published by Springer Nature in Somnologie
- Vol. 28 (2) , 131-137
Open Access33 Praxis-Tipps für müde Eltern, um über den Tag zu kommen
Zusammenfassung: Hintergrund: Viele Eltern berichten, nach der Geburt ihres Kindes übermüdet zu sein und Schwierigkeiten zu haben, den Alltag zu bewältigen. Dies betrifft vor allem erstgebärende Mütter. Schlafmangel und Schlafschwierigkeiten gelten als Risikofaktor für viele Beeinträchtigungen wie Depression, Aggressivität, Abnahme der Beziehungsqualität und Kindeswohlgefährdung. Ziel dieser Arbeit war es daher, eine Reihe an Verhaltensempfehlungen für Eltern zu geben, um einer möglichen Gefährdung der eigenen Person oder des Kindes entgegenzuwirken. Methode: In einem interdisziplinären Team wurden basierend auf der gegenwärtigen Literatur sowie der klinischen Expertise die Empfehlungen formuliert, reflektiert und diskutiert. Ergebnisse: Es wurden insgesamt 33 Verhaltensempfehlungen für müde Eltern formuliert, die sich auf die Person selbst, die Partnerschaft und Familie, den Abend und die Nacht sowie die Arbeit beziehen. Die Empfehlungen sind vor allem für Eltern jüngerer Kinder geeignet. Diskussion: Mithilfe der hier formulierten Empfehlungen sollen alltagsnahe Hilfen geschaffen werden, um Eltern niederschwellig Unterstützung zukommen zu lassen. Solche Tipps können als Selbsthilfemaßnahmen, als Basis für eine Schlafberatung sowie für eine weiterführende ausführliche Behandlung dienen.
- Open Access
- 24 April 2024
- Published by Springer Nature in Somnologie
- Vol. 28 (2) , 103-109
Melatonin in infants—physiology, pathophysiology and intervention options
The effectiveness of melatonin in nonorganic sleep disorders in children and adolescents has been examined in 33 randomised controlled studies [1]. This review presents the current state of knowledge on the physiology, pharmacokinetics, pathophysiology and toxicity of melatonin in infancy based on well-documented studies. Up to the third month of life, premature and full-term babies cannot produce their own melatonin, so they are dependent on exogenous supply via their own mother’s breast milk, non-pooled breast milk or non-pooled formula. Non-pooled means that a distinction should be made between melatonin-rich night milk and melatonin-poor day milk. A number of intervention studies indicate that administration of melatonin to infants may have analgesic and antioxidant effects related to ophthalmological examinations, prevention of bronchopulmonary dysplasia, and the treatment of hypoxic ischaemic encephalopathies. Since melatonin concentrations in the mother’s blood, in breast milk and, e.g., also in cow’s milk show regular day–night fluctuations, and since breastfed infants have a more stable melatonin supply and fewer sleep disorders, infants who cannot be breastfed by their own mother should preferably have chrononutrition made from non-pooled human or cow’s milk. There has recently been evidence that infantile colic is a disorder with delayed development of chronobiological rhythms.
- 24 April 2024
- Published by Springer Nature in Somnologie
- Vol. 28 (2) , 103-109
Open AccessMelatonin in infants—physiology, pathophysiology and intervention options
The effectiveness of melatonin in nonorganic sleep disorders in children and adolescents has been examined in 33 randomised controlled studies [1]. This review presents the current state of knowledge on the physiology, pharmacokinetics, pathophysiology and toxicity of melatonin in infancy based on well-documented studies. Up to the third month of life, premature and full-term babies cannot produce their own melatonin, so they are dependent on exogenous supply via their own mother’s breast milk, non-pooled breast milk or non-pooled formula. Non-pooled means that a distinction should be made between melatonin-rich night milk and melatonin-poor day milk. A number of intervention studies indicate that administration of melatonin to infants may have analgesic and antioxidant effects related to ophthalmological examinations, prevention of bronchopulmonary dysplasia, and the treatment of hypoxic ischaemic encephalopathies. Since melatonin concentrations in the mother’s blood, in breast milk and, e.g., also in cow’s milk show regular day–night fluctuations, and since breastfed infants have a more stable melatonin supply and fewer sleep disorders, infants who cannot be breastfed by their own mother should preferably have chrononutrition made from non-pooled human or cow’s milk. There has recently been evidence that infantile colic is a disorder with delayed development of chronobiological rhythms.
- 12 April 2024
- Published by Georg Thieme Verlag KG in Kinder- und Jugendmedizin
- Vol. 24 (02) , 94-102
Melatonin als ärztliche Verordnung bei Schlafstörungen im Kindes- und Jugendalter?
ZUSAMMENFASSUNG: Melatonin ist ein stark wirksames Hormon, das in der Zirbeldrüse bei Dunkelheit pulsatil synthetisiert und sezerniert wird, sodass das Einschlafen unterstützt wird. Zusätzlich weist Melatonin eine ganze Reihe von Effekten als Radikalfänger auf. Tumore der Zirbeldrüse und der Pinealisregion weisen gleichlautend zu Untersuchungen bei jungen Erwachsenen und zu tierexperimentellen Befunden darauf hin, dass die Gabe von Melatonin u. a. auch negative Einflüsse auf die Pubertätsentwicklung haben kann. Kürzlich wurde über mehrere Todesfälle bei Säuglingen im zeitlichen Zusammenhang mit erheblicher Überdosierung von Melatonin berichtet.Vor dem Hintergrund des begrenzten aktuellen Kenntnisstandes und der unzureichenden Daten über Langzeiteffekte sollte Melatonin bei Kindern und Jugendlichen mit ausgewählten nicht-organischen Schlafstörungen nur zurückhaltend und zunächst nur für maximal 6 Monate eingesetzt werden, nachdem eine ausführliche Anamnese und ein orientierender neurologischer Status erhoben wurden, Hinweise zur Schlafhygiene übermittelt wurden und nachdem verhaltenstherapeutische Interventionen keinen ausreichenden Effekt gezeigt hatten. Der unterschiedliche Zulassungsstatus für Melatoninpräparate in DACH weist auf die unterschiedlichen Grenzen für Verordnungen bzw. für Off-Label-Use hin.
- 12 April 2024
- Published by Georg Thieme Verlag KG in Kinder- und Jugendmedizin
- Vol. 24 (02) , 94-102
Melatonin als ärztliche Verordnung bei Schlafstörungen im Kindes- und Jugendalter?
ZUSAMMENFASSUNG: Melatonin ist ein stark wirksames Hormon, das in der Zirbeldrüse bei Dunkelheit pulsatil synthetisiert und sezerniert wird, sodass das Einschlafen unterstützt wird. Zusätzlich weist Melatonin eine ganze Reihe von Effekten als Radikalfänger auf. Tumore der Zirbeldrüse und der Pinealisregion weisen gleichlautend zu Untersuchungen bei jungen Erwachsenen und zu tierexperimentellen Befunden darauf hin, dass die Gabe von Melatonin u. a. auch negative Einflüsse auf die Pubertätsentwicklung haben kann. Kürzlich wurde über mehrere Todesfälle bei Säuglingen im zeitlichen Zusammenhang mit erheblicher Überdosierung von Melatonin berichtet.Vor dem Hintergrund des begrenzten aktuellen Kenntnisstandes und der unzureichenden Daten über Langzeiteffekte sollte Melatonin bei Kindern und Jugendlichen mit ausgewählten nicht-organischen Schlafstörungen nur zurückhaltend und zunächst nur für maximal 6 Monate eingesetzt werden, nachdem eine ausführliche Anamnese und ein orientierender neurologischer Status erhoben wurden, Hinweise zur Schlafhygiene übermittelt wurden und nachdem verhaltenstherapeutische Interventionen keinen ausreichenden Effekt gezeigt hatten. Der unterschiedliche Zulassungsstatus für Melatoninpräparate in DACH weist auf die unterschiedlichen Grenzen für Verordnungen bzw. für Off-Label-Use hin.